332 related articles for article (PubMed ID: 29073256)
1. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis.
Voigt J; Carpenter L; Leuchter A
PLoS One; 2017; 12(10):e0186950. PubMed ID: 29073256
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
Nguyen KH; Gordon LG
Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
[TBL] [Abstract][Full Text] [Related]
3. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
[TBL] [Abstract][Full Text] [Related]
4. Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder.
Zemplényi A; Józwiak-Hagymásy J; Kovács S; Erdősi D; Boncz I; Tényi T; Osváth P; Voros V
BMC Psychiatry; 2022 Jun; 22(1):437. PubMed ID: 35764989
[TBL] [Abstract][Full Text] [Related]
5. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
8. Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.
Fitzgibbon KP; Plett D; Chan BCF; Hancock-Howard R; Coyte PC; Blumberger DM
Can J Psychiatry; 2020 Mar; 65(3):164-173. PubMed ID: 31801363
[TBL] [Abstract][Full Text] [Related]
9. Psychotherapy and psychopharmacology utilization following repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder.
Needs P; Mote SD; Manocchia M; King JD; Szuba DD; Lustig SL; Shah VN
Psychiatry Res; 2019 Aug; 278():51-55. PubMed ID: 31146141
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis comparing repetitive transcranial magnetic stimulation therapy with antidepressant treatment in patients with treatment-resistant depression in Japan.
Noda Y; Miyashita C; Komatsu Y; Kito S; Mimura M
Psychiatry Res; 2023 Dec; 330():115573. PubMed ID: 37939593
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials.
Vida RG; Sághy E; Bella R; Kovács S; Erdősi D; Józwiak-Hagymásy J; Zemplényi A; Tényi T; Osváth P; Voros V
BMC Psychiatry; 2023 Jul; 23(1):545. PubMed ID: 37501135
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder.
Groessl EJ; Tally SR; Hillery N; Maciel A; Garces JA
J Manag Care Spec Pharm; 2018 Aug; 24(8):726-734. PubMed ID: 30058980
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive.
Ghiasvand H; Moradi-Joo M; Abolhassani N; Ravaghi H; Raygani SM; Mohabbat-Bahar S
Med J Islam Repub Iran; 2016; 30():330. PubMed ID: 27390700
[TBL] [Abstract][Full Text] [Related]
14. [Repetitive transcranial magnetic stimulation in major depression: response factor].
Dumas R; Padovani R; Richieri R; Lançon C
Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
[TBL] [Abstract][Full Text] [Related]
15. Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol.
Bulteau S; Laurin A; Volteau C; Dert C; Lagalice L; Schirr-Bonnans S; Bukowski N; Guitteny M; Simons L; Cabelguen C; Pichot A; Tessier F; Bonnin A; Lepage A; ; ; Vanelle JM; Sauvaget A; Riche VP
Trials; 2020 Apr; 21(1):312. PubMed ID: 32248820
[TBL] [Abstract][Full Text] [Related]
16. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control.
Corlier J; Burnette E; Wilson AC; Lou JJ; Landeros A; Minzenberg MJ; Leuchter AF
J Affect Disord; 2020 Mar; 265():272-277. PubMed ID: 32090751
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of aripiprazole as adjunctive therapy in major depressive disorder: Thai economic model.
Leelahanaj T
J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S43-50. PubMed ID: 21284136
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).
Langguth B; Wiegand R; Kharraz A; Landgrebe M; Marienhagen J; Frick U; Hajak G; Eichhammer P
Neuro Endocrinol Lett; 2007 Oct; 28(5):633-8. PubMed ID: 17984932
[TBL] [Abstract][Full Text] [Related]
19. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
20. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
Berlim MT; Van den Eynde F; Daskalakis ZJ
J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
